Improving asthma management for children in the PICU
Asthma Navigator Intervention to Improve Health Equity in Children
This study is testing a personalized support program to help children aged 5 to 16 with asthma manage their condition better after leaving the Pediatric Intensive Care Unit, especially for those from disadvantaged backgrounds.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 75 (estimated) |
| Ages | 5 Years to 17 Years |
| Sex | All |
| Sponsor | Emory University Academic / other |
| Locations | 1 site (Atlanta, Georgia) |
| Trial ID | NCT06513832 on ClinicalTrials.gov |
What this trial studies
This intervention aims to enhance health equity for children aged 5 to 16.9 years who are admitted to the Pediatric Intensive Care Unit (PICU) for asthma. The study focuses on identifying factors that affect asthma self-management and testing the effectiveness of a personalized asthma navigator intervention at the time of PICU discharge. By addressing social determinants of health, the intervention seeks to improve outcomes for disadvantaged children, particularly those from low-opportunity neighborhoods. The study is conducted at Children's Healthcare of Atlanta, where a significant proportion of asthma admissions come from these areas.
Who should consider this trial
Good fit: Ideal candidates are children aged 5 to 16.9 years who have been admitted to the PICU for asthma.
Not a fit: Patients with conditions such as cystic fibrosis, immune deficiencies, or congenital airway deformities may not benefit from this intervention.
Why it matters
Potential benefit: If successful, this intervention could significantly improve asthma management and health outcomes for disadvantaged children.
How similar studies have performed: Other studies have shown promise in addressing health disparities through targeted interventions, making this approach both relevant and potentially impactful.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Admitted to the PICU for asthma Exclusion Criteria: * Cystic fibrosis * Immune deficiency * Prematurity \<35 weeks * Gestation and congenital airway deformities * Non-English speaker
Where this trial is running
Atlanta, Georgia
- Children's Healthcare of Atlanta — Atlanta, Georgia, United States (Recruiting)
Study contacts
- Principal investigator: Anne Fitzpatrick, PhD, APRN — Emory University
- Study coordinator: Anne Fitzpatrick, PhD, APRN
- Email: anne.fitzpatrick@emory.edu
- Phone: 404-727-9112
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.